Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Zymeworks Stock: A Deep Dive Into Analyst Perspectives (5 Ratings)
Zymeworks 股票：深入了解分析师观点（5 个评级）
Ratings for Zymeworks (NASDAQ:ZYME) were provided by 5 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在过去三个月中，有5位分析师提供了Zymeworks（纳斯达克股票代码：ZYME）的评级，显示了看涨和看跌的观点。
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
下表简要介绍了他们最近的收视率，展示了过去30天中不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $12.4, a high estimate of $16.00, and a low estimate of $10.00. This current average has decreased by 2.75% from the previous average price target of $12.75.
分析师评估的12个月目标股价揭示了进一步的见解，平均目标价为12.4美元，最高估计为16.00美元，低估值为10.00美元。目前的平均价格较之前的平均目标价12.75美元下降了2.75％。
Understanding Analyst Ratings: A Comprehensive Breakdown
了解分析师评级：全面细分
The analysis of recent analyst actions sheds light on...
对分析师最近行为的...
登录免费看全文
登录/注册